Intraoperative esmolol infusion in the absence of opioids spares postoperative fentanyl in patients undergoing ambulatory laparoscopic cholecystectomy

Anesthesia and Analgesia

Volumn 105, Issue 5, 2007, Pages 1255-1262

  Collard, Vincent ^a   Mistraletti, Giovanni ^a   Taqi, Ali ^a   Asenjo, Juan Francisco ^a   Feldman, Liane S ^a   Fried, Gerald M ^a   Carli, Franco ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; DEXAMETHASONE; DROPERIDOL; ESMOLOL; FENTANYL; KETOROLAC; LOCAL ANESTHETIC AGENT; ONDANSETRON; OPIATE; PARACETAMOL; REMIFENTANIL;

ADULT; ARTICLE; CHOLECYSTECTOMY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INFUSION; FEMALE; GENERAL ANESTHESIA; HEALTH CENTER; HOSPITAL DISCHARGE; HUMAN; INTRAOPERATIVE PERIOD; LAPAROSCOPY; MALE; NAUSEA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN INCISION;

EID: 37349102298     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000282822.07437.02     Document Type: Article

References (28)

1. Richardson WS, Fuhrman GS, Burch E, Bolton JS, Bowen JC. Outpatient laparoscopic cholecystectomy. Outcomes of 847 planned procedures. Surg Endosc 2001;15:193-5
2. Lau H, Broks DC. Contemporary outcomes of ambulatory laparoscopic cholecystectomy in a major teaching hospital. World J Surg 2002;26:1117-21
3. Avramov MN, White PF. Use of alfentanil and propofol for outpatient monitored anesthesia care: determining the optimal dosing regimen. Anesth Analg 1997;85:566-72
4. Zhao SZ, Chung F, Hanna DB, Raymunso AL, Cheung RY, Chen C. Dose-response relationship between opioid use and adverse effects after ambulatory surgery. J Pain Symptom Manage 2004;28:35-46
5. Bisgaart T. Analgesic treatment after laparoscopic cholecystectomy. Anesthesiology 2006;104:835-47
6. Song D, White PF. Remifentanil as an adjuvant during Desflurane anesthesia facilitates early recovery after ambulatory surgery. J Clin Anesth 1999;11:364-7
7. Song D, Whitten CW, White PF. Remifentanil infusion facilitates early recovery for obese outpatients undergoing laparoscopic cholecystectomy. Anesth Analg 2000;90:1111-3
8. Davidson EM, Szmuk P, Doursout MF, Chelly J. Antinociceptive and cardiovascular properties of esmolol following formalin injection in rats. Can J Anaesth 2001;48:59-64
9. Coloma M, Chiu JW, White PF, Armbruster SC. The use of esmolol as an alternative to remifentanil during desflurane anesthesia for fast track outpatient gynecologic laparoscopic surgery. Anesth Analg 2001;92:352-7
10. White PF, Wang B, Tang J, Wender RH, Naruse R, Sloninsky A. The effect of intraoperative use of esmolol and nicardipine on recovery after ambulatory surgery. Anesth Analg 2003;97:1633-8
11. Chia YY, Chan MH, Ko NH, Liu K. Role of beta-blockade in anaesthesia and postoperative pain management after hysterectomy. Br J Anaesth 2004;93:799-805
12. Cortinez LI, Brandes V, Munoz HR, Guerrero ME, Mur M. No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. Br J Anaesth 2001;87:866-9
13. White P, Song D. New criteria for fast-tracking after outpatient anesthesia: a comparison with the Modified Aldrete's scoring system. Anesth Analg 1999;88:1069-72
14. Guignard B, Bossard A, Coste C, Sessler D, Lebrault C, Alfonsi P, Fletcher D, Chauvin M. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000;93:409-17
15. Vinik H, Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 1998;86:1307-11
16. Logan DE, Rose JB. Gender differences in post-operative pain and patient controlled analgesia use among adolescent surgical patients. Pain 2004;109:481-7
17. Taenzer AH, Clark C, Curry CS. Gender affects report of pain and function after arthroscopic anterior cruciate ligament reconstruction. Anesthesiology 2000;93:670-5
18. 2 pneumoperitoneum for laparoscopic surgery. Acta Anaesthesiol Scand 1998;42:510-7
19. Sinha R, Lacadie C, Skudlarski P, Wexler BE. Neural circuits underlying emotional distress in humans. Ann N Y Acad Sci 2004;1032:254-7
20. Surguladze SA, Brammer MJ, Young AW, Andrew C, Travis MJ, William SC, Phillips ML. A preferential increase in the extrastriate response to signals of danger. Neuroimage 2003;19:1317-28
21. Ploghaus A, Narain C, Beckmann CF, Clare S, Bantick S, Wise R, Matthews PM, Rawlins JN, Tracey I. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci 2001;15:21:9896-903
22. Sarvey JM, Burgard EC, Decker G. Long-term potentiation: studies in the hippocampal slide. J Neurosci Methods 1989;28:109-24
23. Booze RM, Crisostomo EA, Davis JN. Beta-adrenergic receptors in the hippocampal and retrohippocampal regions of rats and guinea pigs: autoradiographic and immunohistochemical studies. Synapse 1993;13:206-14
24. Gorczynski RI, Shaffer JE, Lee RJ. Pharmacology of ASL-8052, a novel beta-adrenergic receptor antagonist with ultrashort duration of action. J Cardiovasc Pharmacol 1983;5:668-77
25. Wood AJ, Feely J. Pharmacokinetic drug interactions with propanolol. Clin Pharmacokinet 1983;8:253-62
26. Avram MJ, Krejcie TC, Henthorn TK, Niemann CU. B-eta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution. JPET 2004;311:617-24
27. Kalkman CJ, Drummond J. Monitors of depth of anesthesia, quo vadis? Anesthesiology 2002;96:784-7
28. Yang H. Are β-blockers anesthetics? Can J Anaesth 2003;50:627-30